Literature DB >> 11920861

Is there a relationship between Wolfram syndrome carrier status and suicide?

Joanna Crawford1, Marta A Zielinski, Laura J Fisher, Grant R Sutherland, Robert D Goldney.   

Abstract

Wolfram syndrome (WFS) is a rare, autosomal recessive neurodegenerative disorder. An increased risk of psychiatric disorders and suicide has been reported for heterozygote carriers. In this study we investigated whether mutations in the WFS gene are associated with suicide in the general population. The gene for WFS (WFS1) has recently been mapped to chromosome 4p16.1, and its genomic structure has been characterized. We screened the entire WFS1 ORF in a panel of 100 completed suicides, 60 blood donors not known to have psychiatric illness, and 100 donors with a negative history of depression or suicidal behavior. We did not find evidence of an increased incidence of WFS carriers in the suicide panel and concluded that WFS1 carrier status is not a significant contributor to suicide in the general population. Screening of this highly polymorphic gene resulted in the detection of 33 variants, 13 of which cause amino acid changes. Seven of these changes have not been previously reported and six were unique to our suicide panel. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920861     DOI: 10.1002/ajmg.10256

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Endocrine and metabolic aspects of the Wolfram syndrome.

Authors:  Georgios Boutzios; Sarantis Livadas; Evangelos Marinakis; Nicole Opie; Frangiskos Economou; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

2.  Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors:  Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal:  J Physiol Biochem       Date:  2011-04-02       Impact factor: 4.158

3.  Wolframin gene H611R polymorphism: no direct association with suicidal behavior but possible link to mood disorders.

Authors:  Gil Zalsman; Mark J Mann; Yung-Yu Huang; Maria A Oquendo; David A Brent; Ainsley K Burke; Steven P Ellis; J John Mann
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-03-26       Impact factor: 5.067

4.  Prohormone convertase 2 activity is increased in the hippocampus of Wfs1 knockout mice.

Authors:  Karin Tein; Sergo Kasvandik; Sulev Kõks; Eero Vasar; Anton Terasmaa
Journal:  Front Mol Neurosci       Date:  2015-08-25       Impact factor: 5.639

5.  Layer 2/3 pyramidal cells in the medial prefrontal cortex moderate stress induced depressive behaviors.

Authors:  Prerana Shrestha; Awni Mousa; Nathaniel Heintz
Journal:  Elife       Date:  2015-09-15       Impact factor: 8.140

6.  Phenotype Prediction of Pathogenic Nonsynonymous Single Nucleotide Polymorphisms in WFS1.

Authors:  Xuli Qian; Luyang Qin; Guangqian Xing; Xin Cao
Journal:  Sci Rep       Date:  2015-10-05       Impact factor: 4.379

7.  Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.

Authors:  Marite Punapart; Mall Eltermaa; Julia Oflijan; Silva Sütt; Anne Must; Sulev Kõks; Leonard C Schalkwyk; Catherine Fernandes; Eero Vasar; Ursel Soomets; Anton Terasmaa
Journal:  PPAR Res       Date:  2014-04-01       Impact factor: 4.964

8.  Wolfram Syndrome: A Case Report and Review of Clinical Manifestations, Genetics Pathophysiology, and Potential Therapies.

Authors:  N B Toppings; J M McMillan; P Y B Au; O Suchowersky; L E Donovan
Journal:  Case Rep Endocrinol       Date:  2018-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.